Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Evaluation of GLR2007 for Advanced Solid Tumors

NCT04444427

Conditions
Astrocytoma, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • USA002 Lafayette, Indiana, United States
  • USA005 Omaha, Nebraska, United States
  • USA001 Philadelphia, Pennsylvania, United States
  • USA004 Dallas, Texas, United States
View Trial Details
Completed

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

NCT01416688

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 113 locations
View Trial Details
Completed

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

NCT01177397

Conditions
Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +47 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Neuro-Oncology Program Los Angeles, California, United States
  • University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 16 locations
View Trial Details
Completed

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

NCT03090737

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Los Angeles Hematology Oncology Medical Group Los Angeles, California, United States
  • St Vincent Frontier Cancer Center Billings, Montana, United States
  • Broome Oncology Johnson City, New York, United States
View all 17 locations
View Trial Details
Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details

Related conditions